Skip to main content
Erschienen in: Journal of Neuro-Oncology 3/2018

21.09.2018 | Letter to the Editor

The importance of adequate methotrexate and adequate folinic acid rescue doses in the treatment of primary brain lymphoma

verfasst von: Ian J. Cohen

Erschienen in: Journal of Neuro-Oncology | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Excerpt

To the Editor, …
Literatur
1.
Zurück zum Zitat Adhikari N, Biswas A, Gogia A et al (2018) A prospective phase II trial of response adapted radiotherapy after high dose methotrexate based chemotherapy in patients with newly diagnosed primary central nervous system lymphoma-analysis of acute toxicity profile and early clinical outcome. J Neurooncol 139:153–166CrossRefPubMed Adhikari N, Biswas A, Gogia A et al (2018) A prospective phase II trial of response adapted radiotherapy after high dose methotrexate based chemotherapy in patients with newly diagnosed primary central nervous system lymphoma-analysis of acute toxicity profile and early clinical outcome. J Neurooncol 139:153–166CrossRefPubMed
2.
Zurück zum Zitat Cohen IJ, Vogel R, Matz S et al (1986) Successful non-toxic therapy without radiation) of a multifocal primary brain lymphoma with a methotrexate vincristine and BCNU protocol (DEMOB). Cancer 57:6–11CrossRefPubMed Cohen IJ, Vogel R, Matz S et al (1986) Successful non-toxic therapy without radiation) of a multifocal primary brain lymphoma with a methotrexate vincristine and BCNU protocol (DEMOB). Cancer 57:6–11CrossRefPubMed
3.
Zurück zum Zitat Shkalim VS, Toledano H, Ash S et al (2016) Factors affecting the upper limit of the methotrexate (MTX) CSF levels achievable in children with brain tumors reated with high- dose intravenous MTX. J Pediatr Hematol Oncol 38:544–548CrossRef Shkalim VS, Toledano H, Ash S et al (2016) Factors affecting the upper limit of the methotrexate (MTX) CSF levels achievable in children with brain tumors reated with high- dose intravenous MTX. J Pediatr Hematol Oncol 38:544–548CrossRef
4.
Zurück zum Zitat Cohen IJ (2013) Challenging the clinical relevance of folinic acid over rescue after high dose methotrexate(HDMTX). Med Hypotheses 81:942–947CrossRefPubMed Cohen IJ (2013) Challenging the clinical relevance of folinic acid over rescue after high dose methotrexate(HDMTX). Med Hypotheses 81:942–947CrossRefPubMed
Metadaten
Titel
The importance of adequate methotrexate and adequate folinic acid rescue doses in the treatment of primary brain lymphoma
verfasst von
Ian J. Cohen
Publikationsdatum
21.09.2018
Verlag
Springer US
Erschienen in
Journal of Neuro-Oncology / Ausgabe 3/2018
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-018-2999-x

Weitere Artikel der Ausgabe 3/2018

Journal of Neuro-Oncology 3/2018 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Neu im Fachgebiet Neurologie

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.